DEXUS stock
Price history
−17.64% over the period1 year: from $7.20 (November 20, 2025) to $5.93 (November 20, 2026), −17.64%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $5.93 |
| October 30, 2026 | $5.74 |
| September 30, 2026 | $5.74 |
| August 31, 2026 | $5.78 |
| July 31, 2026 | $5.99 |
| June 30, 2026 | $5.40 |
| May 29, 2026 | $5.61 |
| April 30, 2026 | $6.23 |
| March 31, 2026 | $5.92 |
| February 27, 2026 | $6.71 |
| January 30, 2026 | $6.72 |
| December 31, 2025 | $6.93 |
| November 28, 2025 | $7.16 |
| November 20, 2025 | $7.20 |
At a glance
The company
Leading Australasian real asset group managing a portfolio of office, industrial, retail, healthcare and infrastructure investments valued at 51.4 billion dollars
Latest results
Quarter to June 30, 2026 · EPS $0.11 (estimate $20.00)
Next event
TickerLandia's take on DEXUS
- Pricier than usual relative to earnings: P/E on the latest fiscal year 14 vs a median of 10 over its last 8 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 11 vs 11 (+0%) in a group of 5.
- Strong point: Profitability (69/100 in its group). Weak point: Earnings stability (13/100).
- “Best dividend stocks” (Australia): No. 3 of 11.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−20.24% from the 52-week high
Analysts · 11 analysts
Average target$6.48+9.28% vs. price
Buy 4 · Hold 6 · Sell 1 · Hold
TickerLandia Fingerprint: DEXUS
Compared with similar companies: very low earnings stability.
Financials and price compared with 8 companies in the reit - office industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Priceaverage41
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 4.76 44 P/E (trailing 12 months) 10.8 50 Forward P/E 10.3 50 EV/EBITDA 12.0 6 Price/book 0.64 56 Profitabilityhigh69
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 66.8% 56 ROE 4.8% 56 Gross margin 90.4% 69 Net margin 46.1% 69 ROA 3.6% 94 Earnings stabilityvery low13
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 57.0% 6 Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 19 Growthaverage51
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) −12.10% 19 Earnings growth (year over year) −38.50% 42 Average revenue growth (3 years) +26.91% 94 Financial strengthhigh69
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.47 94 Current ratio 0.28 19 Net debt/EBITDAcounts in reverse: lower means more financial strength 5.10 94 Interest coverage 3.82 69 Dividendlow37
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 6.2% 36 Payout ratio 67.3% 31 Consecutive dividend years at least 23 years 44 Market momentumaverage49
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +6.43% 60 Relative strength (6 months) −2.60% 46 Distance from 200-day average +0.48% 66 1-year return −17.64% 24 Risklow28
How much the price swings.
Metric Value Position in group Beta (1 year) 0.56 37 Maximum drawdown (12 months) 28.0% 36 Volatility (60 days) 21.7% 11
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
DEXUS is pricier than in the past and in line with similar companies
On the latest fiscal year's earnings (2026), DEXUS's P/E today is 13.7, above the median of its last 8 fiscal years (10.3; between 5.71 and 52.4 from 2017 to 2026). DEXUS's P/E (trailing 12 months): 10.8, in line with the median of a group of 5 similar companies (10.8).
Compared with 5 similar companies
| Metric | DEXUS | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 10.8 | Middle | |
| Forward P/E | 10.3 | Middle | |
| ROE | 4.8% | Middle | |
| Price/book | 0.64 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: DEXUS. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$636.8M
Latest quarter · Q2 2026
Net income
$245.8M
Latest quarter · Q2 2026
Quarterly net margin
38.6%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $6.31B
- P/E
- 10.8
- EPS
- $0.55
- Volume
- 3.05M
- Daily trading
- €12.73M
- Dividend yield
- 6.24%
- Last ex-dividend on June 29, 2026
How DEXUS is changing
All resultsRevenue fell 3.5% a year on average over the last 5 years
Profitable in 3 of 5 fiscal years
Returns
DEXUS returns with dividends
$1,000 invested in DEXUS 5 years ago, on November 22, 2021, would be worth $727 today with dividends reinvested: −27.30% in total, −6.19% per year. On price alone it would be $540 (−45.99%).
| Period | DEXUS | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | +5.52% | −2.54% | $1,055 |
| 6 months | −1.50% | +1.13% | $985 |
| Year to date | −14.43% | −1.40% | $856 |
| 1 year | −12.65% | +0.47% | $873 |
| 3 years | +0.42% | +21.74% | $1,004 |
| 5 years | −27.30% | +16.86% | $727 |
| 10 years | +14.74% | +60.57% | $1,147 |
Over the last 6 months it has done better than 37% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
DEXUS: technical analysis
DEXUS shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 57.3% below its all-time closing high ($13.90, July 5, 2019).
- Trend
- No clear trend
- RSI (14 sessions)
- 52
- Between 30 and 70
- vs 200-session average
- +0.48%
Support and resistance
Price areas where DEXUS has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$6.74+13.62%2 touches, last on February 27, 2026
- Resistance$6.16+3.79%3 touches, last on August 6, 2026
- Resistance$6.05+1.97%3 touches, last on November 6, 2026
- Last price$5.93
- Support$5.93−0.08%2 touches, last on August 26, 2026
- Support$5.82−1.85%3 touches, last on September 30, 2026
- Support$5.62−5.31%3 touches, last on September 18, 2026
Volatility and risk
Over the last year it has moved less than the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.56
- Volatility (60 sessions, annualised)
- 21.7%
- Largest fall in the last year
- −27.97%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
DEXUS: seasonality
Average monthly price change over 22 years
Over the last 22 years, the strongest month for DEXUS has been April: +2.78% on average, positive in 17 years out of 22. The weakest has been June: −2.87% on average, positive in 4 years out of 22. November, the current month, has been positive in 16 years out of 22 (+2.25% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.17% | −1.22% | 9 of 22 |
| February | +1.11% | +1.57% | 13 of 22 |
| March | −0.96% | −0.18% | 11 of 22 |
| April | +2.78% | +3.56% | 17 of 22 |
| May | −0.14% | +0.55% | 13 of 22 |
| June | −2.87% | −0.86% | 4 of 22 |
| July | +2.73% | +4.60% | 15 of 22 |
| August | +0.68% | +1.11% | 12 of 22 |
| September | −1.54% | −1.22% | 7 of 22 |
| October | −1.74% | +0.43% | 12 of 22 |
| November | +2.25% | +2.02% | 16 of 22 |
| December | −0.68% | −0.85% | 9 of 22 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
DEXUS and its competitors
Its largest business is funds management, which manages 36.1 billion Australian dollars of investment for third-party capital, offering access to office, industrial, retail, healthcare and infrastructure assets through targeted and diversified vehicles. The Dexus listed portfolio, valued at 15.3 billion dollars, holds direct and indirect stakes in similar asset classes as well as alternatives, while a 12.8 billion dollar development pipeline supports both the listed and fund portfolios. Operations span Australasia, and the group reports more than 33,900 investors from 28 countries.
- Headquarters
- Sydney, Australia
- Employees
- 836
- Founded
- 2004
- Chief executive
- Ross G. Vernet
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| DEXUSDXS | $4.2B | 4.8% | 10.8 | −1.50% |
| GecinaGFC | $5.03B | 1.6% | 28.5 | −14.51% |
| Colonial SFL, Socimi S. A.COL | $3.35B | 5.4% | 8.85 | −12.25% |
| Alexandria Real Estate EquitiesARE | $7.32B | -6.2% | — | −15.97% |
| MERLIN Properties SOCIMIMRL | $7.79B | 10.0% | 7.90 | −25.44% |
| BxpBXP | $11.06B | 9.0% | 18.3 | +2.24% |
Same industry or related industries, similar size. Compare DEXUS with its competitors · Full profile
